Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EyeStart is a Canadian medtech and life sciences accelerator focused primarily on ophthalmology and related healthcare innovation. The company describes itself as an accelerator for early-stage biotechnology, medical device, and life sciences projects, with an emphasis on growing ophthalmic start-ups through mentoring, thought leadership, strategic connections, and venture support. Its activities appear to center on company building, clinical insight, and commercialization support rather than advancing a proprietary therapeutic drug pipeline. Publicly visible work includes collaboration with eSight on development and patient screening related to vision-enhancing devices, as well as advisory and ecosystem-building activities in eye care innovation. For a biotech analyst, EyeStart is best understood as an active private ophthalmology-focused incubator/accelerator rather than a traditional therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EyeStart.